Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

MicroStrategys Stock Falls After Announcing Convertible Senior Notes Offering for Bitcoin Acquisition

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Technology Artificial intelligence Markets and money
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

MicroStrategy‘s stock took a hit today following the announcement of pricing for its offering of $525 million in convertible senior notes due 2031. This offering, which was originally set at $500 million, includes an option to purchase an additional $78.75 million in notes. The closing date for this offering is scheduled for March 18, pending customary conditions.

The company intends to use the proceeds from this offering to acquire more Bitcoin and for general corporate purposes. As of March 10, MicroStrategy held approximately 205,000 bitcoins, purchased at an average price of around $33,706 per coin.

MicroStrategy Incorporated (MSTR) Stock Price Sees Slight Decrease on March 15, 2024 – Investors Should Monitor Performance for Informed Decisions

On March 15, 2024, MicroStrategy Incorporated (MSTR) saw a slight decrease in its stock price, trading near the top of its 52-week range and above its 200-day simple moving average. MSTR opened at $1.60K, $75.62 lower than its previous close. MSTR shares experienced a decrease of $7.85, representing a 0.47% drop in price. Despite the decrease in price on this particular day, MSTR has been performing well overall, trading near the top of its 52-week range. Investors should continue to monitor MSTR’s performance in the coming days and weeks to make informed decisions about their investments.

MSTR Stock Update: Flat Revenue But Significant Increase in Net Income and EPS on March 15, 2024

On March 15, 2024, investors in MSTR stock were closely monitoring the company’s financial performance as it released its latest earnings report. MSTR reported total revenue of $496.26 million for the past year, which remained flat compared to the previous year. The total revenue for the fourth quarter of the year was $124.48 million, also holding flat since the previous quarter. MSTR reported a significant increase in net income, with a 129.2% increase for the past year and a net income of $429.12 million. The net income for the fourth quarter was $89.13 million, holding flat since the previous quarter. MSTR reported an EPS of $26.42 for the past year, a 120.35% increase compared to the previous year, and an EPS of $4.96 for the fourth quarter, showing a 149.22% increase since the previous quarter. Overall, MSTR’s financial performance on March 15, 2024, showed mixed results, with flat total revenue but significant increases in net income and EPS. Investors will be closely monitoring MSTR’s future performance to see if the positive trends continue and if the company can sustain its growth trajectory.

Tags: MSTR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

SELLAS Life Sciences Group Faces Stock Decline After Announcing Registered Direct Offering and Private Placement

Finances

Investor Sentiment and Options Activity for Halliburton on March 15 2024

MA stock news

Analyst Reaffirms Neutral Rating on Solo Brands with Adjusted Price Target

Recommended

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

2 years ago
Portillo's Stock

Leadership Turmoil Sends Portillo’s Shares to New Low

2 months ago
Dine Brands Global Stock

Dine Brands Stock Faces Potential Downturn

1 month ago
Intel Stock

US Government Considers Taking Equity Stake in Intel

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Trending

XRP Stock
Analysis

XRP Market Dynamics: Institutional Pause Meets Accumulation Surge

by Andreas Sommer
January 11, 2026
0

The XRP market is currently defined by a stark divergence in investor behavior. After a powerful rally...

Rocket Lab USA Stock

Rocket Lab’s Stock Momentum Continues Unabated in 2026

January 11, 2026
Eli Lilly Stock

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

January 11, 2026
Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XRP Market Dynamics: Institutional Pause Meets Accumulation Surge
  • Rocket Lab’s Stock Momentum Continues Unabated in 2026
  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com